Viviane Dubruille

机构：Centre Hospitalier Universitaire de Nantes, Centre Léon Bérard, Institut Bergonié

发表论文 169 篇 · 总被引 3479 次 · h-index 29

代表论文

• Momelotinib long-term safety and survival in myelofibrosis: integrated analysis of phase 3 randomized controlled trials (2023 · Blood Advances · 被引 51)
• Momelotinib vs. ruxolitinib in myelofibrosis patient subgroups by baseline hemoglobin levels in the SIMPLIFY-1 trial (2024 · Leukemia & lymphoma/Leukemia and lymphoma · 被引 17)
• Identification of Hepatic-like EPO as a Cause of Polycythemia (2025 · New England Journal of Medicine · 被引 13)
• Phase I study of zoledronic acid combined with escalated doses of interleukine‐2 for early in vivo generation of Vγ9Vδ2 T ‐cells after haploidentical stem cell transplant with posttransplant cyclophosphamide (2024 · American Journal of Hematology · 被引 5)
• Immune-related adverse events with bispecific T-cell engager therapy targeting B-cell maturation antigen. (2023 · Haematologica · 被引 5)
• Quad‐class exposed/refractory myeloma is associated with short survival (2023 · British Journal of Haematology · 被引 4)